Back to Search
Start Over
Pricing and welfare implications of parallel imports in the pharmaceutical industry.
- Source :
- International Journal of Health Care Finance & Economics; Mar2005, Vol. 5 Issue 1, p5-21, 17p
- Publication Year :
- 2005
-
Abstract
- In this paper we investigate the implications of permitting parallel imports of pharmaceuticals produced by a monopoly, from one country to another. We use a model where countries differ in the patients' level of co-payment for buying pharmaceuticals, and patients differ in the utility obtained from the consumption of pharmaceuticals. We show that the effects of parallel imports on total welfare are as follows: On the one hand, when countries differ in their health system only, parallel imports decrease total welfare; On the other hand, when countries differ in the health needs of their patients only, parallel imports enhance total welfare. [ABSTRACT FROM AUTHOR]
- Subjects :
- PHARMACEUTICAL industry
IMPORTS
DRUGS
ECONOMETRIC models
PHARMACEUTICAL services insurance
PUBLIC welfare
PRICES
INDUSTRIAL laws & legislation
INDUSTRIES & economics
PUBLIC welfare laws
ECONOMICS
MEDICAL care cost statistics
COMPARATIVE studies
INTERNATIONAL relations
RESEARCH methodology
MEDICAL needs assessment
MEDICAL cooperation
PATENTS
RESEARCH
USER charges
EVALUATION research
ECONOMIC competition
STATISTICAL models
Subjects
Details
- Language :
- English
- ISSN :
- 13896563
- Volume :
- 5
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- International Journal of Health Care Finance & Economics
- Publication Type :
- Academic Journal
- Accession number :
- 16272961
- Full Text :
- https://doi.org/10.1007/s10754-005-6599-x